Paul Berns
InvestorManaging Director at ARCH Venture Partners · Board director at Mirador Therapeutics · Board director at Areteia Therapeutics · Board director at Neumora Therapeutics
Wisconsin
Writes $50K – $150M checks · typically $25M
About
Paul Berns is a pharma operator who helped architect Humira, led Anacor (sold to Pfizer for over $5 billion), co-founded and runs Neumora, with unusually direct large-scale commercialization experience.
Likely email· guessed from name + firm domain, not firm-published
- p•••@archventure.comreveal100% confident
Invests in
AI & Machine LearningBiotechDeep TechHardwareHealthtechMedical Devices
Board director at Mirador Therapeutics
Intro paths
In turn, Paul can intro founders to Mirador Therapeutics's investors below.
Mirador Therapeutics's investors · 3
Co-founders at Mirador Therapeutics
Board director at Areteia Therapeutics
Intro paths
In turn, Paul can intro founders to Areteia Therapeutics's investors below.
Areteia Therapeutics's investors · 7
Board director at Neumora Therapeutics
Intro paths
In turn, Paul can intro founders to Neumora Therapeutics's investors below.
Neumora Therapeutics's investors · 9
Deals · 1
Ollin Biosciences, Inc.Board seat
via ARCH Venture Partners · filed Jun 2026 · $330M raise
Attribution from SEC filings, press coverage, and firm rosters.
Other disclosed investments
Per SEC Form D filings.
Colleagues at ARCH Venture Partners
Network1
Investors connected to Paul in public investor directories — a warm-intro map.
Frequently asked questions
- Who is Paul Berns?
- Paul Berns is a pharma operator who helped architect Humira, led Anacor (sold to Pfizer for over $5 billion), co-founded and runs Neumora, with unusually direct large-scale commercialization experience.
- Where does Paul Berns work?
- Paul Berns is Managing Director at ARCH Venture Partners and Board director at Mirador Therapeutics and Board director at Areteia Therapeutics and Board director at Neumora Therapeutics.
- What does Paul Berns invest in?
- Paul Berns invests in AI & Machine Learning, Biotech, Deep Tech, Hardware, Healthtech, Medical Devices.
- What check size does Paul Berns write?
- Paul Berns typically writes checks of $50K – $150M.
- What boards does Paul Berns sit on?
- Paul Berns holds tracked board seats at Areteia Therapeutics, Elephas Biosciences, Metsera, Mirador Therapeutics, Ollin Biosciences, Inc..